GlobalData
GlobalData

shankar besta

  • Home
  • Author: shankar besta

Boston Scientific’s Watchman FLX key driver of structural heart occlusion devices market’s aggressive growth, finds GlobalData

The structural heart occlusion (SHO) devices market registered aggressive growth in recent years, with a compound annual growth rate (CAGR) of 25% from 2015-2022. Driven mainly by Boston Scientific’s Watchman FLX device, this market has grown over 150% in 2022 compared to 2019, far outpacing other cardiovascular device markets. The SHO devices market is forecast […]
Read more

Sexual and reproductive health market will continue to expand through 2030, forecasts GlobalData

The global medical devices market is poised for significant growth in the coming years, with the sexual and reproductive health segment expected to experience robust expansion through 2030,  driven by increasing demand for healthcare services and technological advancements that promote the development of safe and effective products, says GlobalData, a leading data and analytics company. […]
Read more

Singapore’s Nutri-Grade system effective in promoting innovation in health beverages, says GlobalData

Singapore’s Nutri-Grade nutrient labeling system is proving to be a useful tool in stimulating competition and product innovation in the health and wellness beverages space and curbing sales of unhealthy drinks. Notably, 53% of Singaporean respondents said that health labeling (information on protein/sugar/fiber/carbohydrate content) displayed on the product packaging often or always influences their product […]
Read more

Music Therapy Awareness Month and medical device market share a crucial connection, says GlobalData

Music therapy is gaining popularity as it can help reduce anxiety, stress, and perceived pain levels during medical procedures requiring the use of medical devices. Moreover, it can enhance motor function and cognitive abilities in patients with neurological disorders and improve mental health and well-being in patients with psychiatric disorders. The medical device market and […]
Read more

Antimicrobial resistance takes centre stage at ECCMID 2023, says GlobalData

Navigating the ever-increasing challenges of antimicrobial resistance (AMR), which occurs when bacteria, viruses, fungi, or parasites no longer respond to antimicrobial treatment, has been a key theme at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2023 conference, says GlobalData, a leading data and analytics company. Stephanie Kurdach, Infectious Disease Analyst at GlobalData, […]
Read more

FDA rejection to dent mirikizumab’s chances to become first-to-market IL-23 inhibitor therapy for ulcerative colitis in US, says GlobalData

The FDA recently rejected Eli Lilly’s biologic license application (BLA) for their anti-interleukin (IL) -23, mirikizumab, which is in development for the treatment of ulcerative colitis (UC). This news will likely delay mirikizumab’s entry into the US market as it will inevitably fall behind competitors, which are aiming to enter the UC market during 2021-31, […]
Read more
1 115 116 117 118 119 136